Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02211911Phase 1Completed
Phase 1, open-label trial of bisacodyl and sodium picosulfate in constipation (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum measured concentration in plasma up to 8 days, Time to maximum concentration up to 8 days and 5 more. Started Feb 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02211911.